By Bhanvi Satija and Mariam Sunny Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer ...
The plan raises a number of questions, including how the payments will be distributed across large teams of staffers.
By Kamal Choudhury and Sneha S K Feb 26 (Reuters) - The U.S. Food and Drug Administration plans to give quarterly bonuses to ...
Feb 26 (Reuters) - The U.S. Food and Drug Administration plans to give quarterly bonuses to scientific staff for completing ...
The Food and Drug Administration warning letter detailed unreported hypoglycemic episodes and a software change to correct ...
The US Food and Drug Administration plans to give bonuses to scientific staff for speeding up drug reviews, according to an ...
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...
The US Food and Drug Administration (FDA) is relaxing a long-standing drug approval requirement for common diseases.
Exposure to the product "may cause temporary or medically reversible adverse health consequences," according to the FDA.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results